2007
DOI: 10.4161/hv.3.5.4458
|View full text |Cite
|
Sign up to set email alerts
|

Post-Marketing Safety Monitoring of a New Group B Meningococcal Vaccine in New Zealand, 2004-2006

Abstract: New Zealand introduced a new outer membrane vesicle vaccine in 2004 to combat an epidemic of group B meningococcal disease. An Independent Safety Monitoring Board oversaw intensive safety monitoring, which included hospital surveillance, health professional reporting (passive and active) and mortality monitoring. With over three million doses administered to individuals aged under 20 years, the monitoring results provide consistent evidence supporting the vaccine's safety.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
32
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(33 citation statements)
references
References 0 publications
1
32
0
Order By: Relevance
“…There was one report of a hypotensive hyporesponsive episode with onset of symptoms 30 min post vaccine [35,52,56]. Eighteen cases of Kawasaki disease were reported in children under 5 years of age, of which only eight had received MenZB prior to the disease onset [52]. Seventeen seizures in children under 5 years were noted in surveillance areas within 4 days of vaccination, of which 11 were simple febrile seizures, and two of these had no other attributable cause.…”
Section: Previous Experience With Outer Membrane Vesicle Vaccinesmentioning
confidence: 97%
See 3 more Smart Citations
“…There was one report of a hypotensive hyporesponsive episode with onset of symptoms 30 min post vaccine [35,52,56]. Eighteen cases of Kawasaki disease were reported in children under 5 years of age, of which only eight had received MenZB prior to the disease onset [52]. Seventeen seizures in children under 5 years were noted in surveillance areas within 4 days of vaccination, of which 11 were simple febrile seizures, and two of these had no other attributable cause.…”
Section: Previous Experience With Outer Membrane Vesicle Vaccinesmentioning
confidence: 97%
“…There was one report of a hypotensive hyporesponsive episode with onset of symptoms 30 min post vaccine [35,52,56]. Eighteen cases of Kawasaki disease were reported in children under 5 years of age, of which only eight had received MenZB prior to the disease onset [52].…”
Section: Previous Experience With Outer Membrane Vesicle Vaccinesmentioning
confidence: 98%
See 2 more Smart Citations
“…18 This resulted for our base case in the prediction of 479 adverse event related GP visits and 1 hospitalisation.…”
mentioning
confidence: 99%